Osobní účet
Osobní účet
Sana Biotechnology
Developer of engineered cells intended to be used as medicine for patients
Stránky společnostiRok založení
2018
Uzávěrka
2/23/2021
Ziskovost
36.64%
O společnosti
Total Funding
$700M
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients.
Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases.
The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
Number of employees
100-250
Headquarters
Seattle, Washington, United States